| Robert Bryan Dorman, MD | |
|
115 Medical Cir Ste 107, Athens, TX 75751-9004 | |
| (903) 675-5781 | |
| (903) 677-1008 |
| Full Name | Robert Bryan Dorman |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 17 Years |
| Location | 115 Medical Cir Ste 107, Athens, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740423839 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | E-8173 (Arkansas) | Secondary |
| 208600000X | Surgery | S4461 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ut Health East Texas Athens Hospital | Athens, TX | Hospital |
| Ut Health East Texas Jacksonville Hospital | Jacksonville, TX | Hospital |
| Ut Health East Texas Tyler Regional Hospital | Tyler, TX | Hospital |
| The University Of Texas Health Science Center At Tyler | Tyler, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Etmc Physician Group, Inc. | 4486915600 | 276 |
News Archive
The Hong Kong's Centre for Health Protection has confirmed another enterovirus 71 in a 21-month-old boy, bringing this year's total to 34. He travelled to the Mainland from September 3 to 5.
It contains potentially lifesaving stem cells that can treat a host of blood-based cancers and other diseases. Yet the blood found in newborns' umbilical cords is almost always discarded as medical waste, rather than banked for future needs.
BioInvent International AB and ThromboGenics NV announce that the positive results from a Phase II trial of TB-402 (Anti-Factor VIII antibody) were presented at the 21st International Congress on Thrombosis in Milan, Italy yesterday. TB-402 is a novel, long acting anticoagulant that is being developed as a single injection for the prevention of venous thromboembolism following orthopaedic surgery.
Rural hospitals could provide critical help addressing the state's expected doctor shortage, according to Dr. Douglas Girod, the new executive vice chancellor of the University of Kansas Medical Center.
Modern Healthcare: "Pharmacy-benefit manager Medco Health Solutions' recent announcement of plans to acquire United BioSource Corp. for $730 million has many wondering if this will be the first of many companies seeking to extend their reach in the growing comparative effectiveness market.
› Verified 1 days ago
| Entity Name | Cherokee Nation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780692723 PECOS PAC ID: 5799698742 Enrollment ID: O20031106000628 |
News Archive
The Hong Kong's Centre for Health Protection has confirmed another enterovirus 71 in a 21-month-old boy, bringing this year's total to 34. He travelled to the Mainland from September 3 to 5.
It contains potentially lifesaving stem cells that can treat a host of blood-based cancers and other diseases. Yet the blood found in newborns' umbilical cords is almost always discarded as medical waste, rather than banked for future needs.
BioInvent International AB and ThromboGenics NV announce that the positive results from a Phase II trial of TB-402 (Anti-Factor VIII antibody) were presented at the 21st International Congress on Thrombosis in Milan, Italy yesterday. TB-402 is a novel, long acting anticoagulant that is being developed as a single injection for the prevention of venous thromboembolism following orthopaedic surgery.
Rural hospitals could provide critical help addressing the state's expected doctor shortage, according to Dr. Douglas Girod, the new executive vice chancellor of the University of Kansas Medical Center.
Modern Healthcare: "Pharmacy-benefit manager Medco Health Solutions' recent announcement of plans to acquire United BioSource Corp. for $730 million has many wondering if this will be the first of many companies seeking to extend their reach in the growing comparative effectiveness market.
› Verified 1 days ago
| Entity Name | Healogics Specialty Physicians Of Texas Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285051094 PECOS PAC ID: 6709002777 Enrollment ID: O20140728002064 |
News Archive
The Hong Kong's Centre for Health Protection has confirmed another enterovirus 71 in a 21-month-old boy, bringing this year's total to 34. He travelled to the Mainland from September 3 to 5.
It contains potentially lifesaving stem cells that can treat a host of blood-based cancers and other diseases. Yet the blood found in newborns' umbilical cords is almost always discarded as medical waste, rather than banked for future needs.
BioInvent International AB and ThromboGenics NV announce that the positive results from a Phase II trial of TB-402 (Anti-Factor VIII antibody) were presented at the 21st International Congress on Thrombosis in Milan, Italy yesterday. TB-402 is a novel, long acting anticoagulant that is being developed as a single injection for the prevention of venous thromboembolism following orthopaedic surgery.
Rural hospitals could provide critical help addressing the state's expected doctor shortage, according to Dr. Douglas Girod, the new executive vice chancellor of the University of Kansas Medical Center.
Modern Healthcare: "Pharmacy-benefit manager Medco Health Solutions' recent announcement of plans to acquire United BioSource Corp. for $730 million has many wondering if this will be the first of many companies seeking to extend their reach in the growing comparative effectiveness market.
› Verified 1 days ago
| Entity Name | Etmc Physician Group, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609382662 PECOS PAC ID: 4486915600 Enrollment ID: O20180305002106 |
News Archive
The Hong Kong's Centre for Health Protection has confirmed another enterovirus 71 in a 21-month-old boy, bringing this year's total to 34. He travelled to the Mainland from September 3 to 5.
It contains potentially lifesaving stem cells that can treat a host of blood-based cancers and other diseases. Yet the blood found in newborns' umbilical cords is almost always discarded as medical waste, rather than banked for future needs.
BioInvent International AB and ThromboGenics NV announce that the positive results from a Phase II trial of TB-402 (Anti-Factor VIII antibody) were presented at the 21st International Congress on Thrombosis in Milan, Italy yesterday. TB-402 is a novel, long acting anticoagulant that is being developed as a single injection for the prevention of venous thromboembolism following orthopaedic surgery.
Rural hospitals could provide critical help addressing the state's expected doctor shortage, according to Dr. Douglas Girod, the new executive vice chancellor of the University of Kansas Medical Center.
Modern Healthcare: "Pharmacy-benefit manager Medco Health Solutions' recent announcement of plans to acquire United BioSource Corp. for $730 million has many wondering if this will be the first of many companies seeking to extend their reach in the growing comparative effectiveness market.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robert Bryan Dorman, MD 1101 S Horsebarn Rd, Rogers, AR 72758-8237 Ph: (479) 271-9607 | Robert Bryan Dorman, MD 115 Medical Cir Ste 107, Athens, TX 75751-9004 Ph: (903) 675-5781 |
News Archive
The Hong Kong's Centre for Health Protection has confirmed another enterovirus 71 in a 21-month-old boy, bringing this year's total to 34. He travelled to the Mainland from September 3 to 5.
It contains potentially lifesaving stem cells that can treat a host of blood-based cancers and other diseases. Yet the blood found in newborns' umbilical cords is almost always discarded as medical waste, rather than banked for future needs.
BioInvent International AB and ThromboGenics NV announce that the positive results from a Phase II trial of TB-402 (Anti-Factor VIII antibody) were presented at the 21st International Congress on Thrombosis in Milan, Italy yesterday. TB-402 is a novel, long acting anticoagulant that is being developed as a single injection for the prevention of venous thromboembolism following orthopaedic surgery.
Rural hospitals could provide critical help addressing the state's expected doctor shortage, according to Dr. Douglas Girod, the new executive vice chancellor of the University of Kansas Medical Center.
Modern Healthcare: "Pharmacy-benefit manager Medco Health Solutions' recent announcement of plans to acquire United BioSource Corp. for $730 million has many wondering if this will be the first of many companies seeking to extend their reach in the growing comparative effectiveness market.
› Verified 1 days ago
Dr. Danny P Pugh, Surgery Medicare: Accepting Medicare Assignments Practice Location: 115 Medical Cir, Suite 107, Athens, TX 75751 Phone: 903-675-5781 Fax: 903-677-1008 |